TKMS Bulls Face a Liquidity Reckoning as Berlin's Frigate Approval Meets a Cautious Cash View

Two brokers landed on the same 115-euro price target for TKMS on Monday, but they arrived there from opposite directions — and that divergence says more about the investment case than the shared number does.

Deutsche Bank Research nudged its target up from 112 to 115 euros while keeping a buy recommendation, citing anticipated strong order intake and operating results in fiscal 2025/26. Bernstein Research moved the other way, trimming its target from 120 to 115 euros on lower liquidity assumptions, though it stuck with an "Outperform" rating. The identical destination masks two very different adjustments to prior valuations.

At a current share price of 84.90 euros, mwb Research's buy recommendation and 140-euro target sit well above both. Yet the same house has cut its near-term free cash flow estimates, citing timing effects and capital expenditure. The optimistic growth view, in other words, no longer travels with matching confidence about short-term cash generation.

Eight Frigates, Two Different Statuses

The order backdrop is genuinely substantial. In October, the Bundestag's budget committee approved procurement of four additional MEKO A-200 DEU frigates, bringing the program to eight vessels alongside the four already ordered.

The distinction between those two batches matters. TKMS described the earlier ships as already commissioned; for the expansion, it reported the budget committee's approval of procurement. Those statements are not equivalent to an operating result already booked. The company also said in October that the first frigate should be handed over to the German Navy as planned at the end of 2029 — a delivery schedule that underscores the program's long-term character. No near-term earnings contribution can be inferred from the procurement decision alone.

mwb Research expects revenue growth of more than 16% for fiscal 2025/26, above the company's own raised guidance of +10–12%. That gap is an analyst projection, not a fresh corporate commitment. The same house models an adjusted EBIT margin of roughly 6.3% and an order backlog of around 25 billion euros — again estimates rather than reported figures. Notably, the second MEKO batch is not included in that backlog, nor are India, Canada or F127. Those projects are potential upside, not secured additional business, and cannot offset weaker cash flow or serve today as proof of future growth.

Cash Flow Becomes the Deciding Metric

For investors, the crux is whether strong growth actually converts into free cash. Rising profit and a stronger cash surplus are not the same thing. As long as investment and payment timing weigh on liquidity, higher revenue expectations alone cannot be read as an easing of free cash flow.

Bernstein's cut illustrates the point: even bullish analysts adjust valuations when expected liquidity softens. That is not a reversal of the positive stance — it is a recalibration. mwb, by contrast, has held its high target even as its short-term cash outlook dims. The two houses differ, in effect, on how much weight liquidity deserves.

The positive scenario rests on two pillars. TKMS would need to grow faster and operate more profitably than the company itself has guided, and it would need to show that near-term cash drags do not permanently impair the longer-term liquidity picture. Bernstein sees operating opportunities too: marine business results could significantly beat market expectations, and the house anticipates an upgrade to the medium-term EBIT target. That upgrade remains an analyst expectation, not a confirmed company decision.

What December Will and Won't Settle

The serious bear argument is not that the operating business must disappoint. A persistently weaker free cash flow trend could be enough on its own to blunt the market impact of higher earnings assumptions. The most unfavorable combination for shareholders would be an expected operating beat that fails to materialize just as cash generation comes in softer — eroding both supporting arguments at once.

The next fixed checkpoint is the annual financial report, scheduled for 7 December 2026. Until then, the central question is not simply whether TKMS raises its earnings targets. It is whether higher targets arrive alongside a more convincing liquidity outlook. Additional disclosure on capital expenditure, payment timing and free cash flow development would carry particular weight.

Worth keeping separate from all of this: the recent sector move. According to media reports, Friday's rise in defense stocks had no single company-specific trigger. For TKMS, the gap between general market optimism and demonstrated business performance remains the line that matters.